Mitochondrial permeability transition as the critical target of N-acetyl perfluorooctane sulfonamide toxicity in vitro

Toxicological Sciences

Volumn 82, Issue 1, 2004, Pages 333-340

  O'Brien, Timothy M ^a   Wallace, Kendall B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Mitochondria; Permeability transition; PFOA; PFOS

Indexed keywords

CYCLOSPORIN A; CYTOCHROME C; PERFLUOROOCTANE; PERFLUOROOCTANOIC ACID; REACTIVE OXYGEN METABOLITE; SULFONAMIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER MITOCHONDRION; MALE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; MOLECULAR MECHANICS; NONHUMAN; OXYGEN CONSUMPTION; RAT; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; CYTOCHROMES C; FLUOROCARBONS; MALE; MITOCHONDRIA, LIVER; MITOCHONDRIAL SWELLING; OCTANOIC ACIDS; PERMEABILITY; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 8444224229     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh244     Document Type: Article

References (40)

1. Appaix, F., Minatchy, M., Riva-Lavieille, C., Olivares, J., Antonsson, B., and Saks, V. A. (2000). Rapid spectrophotometric method for quantitation of cytochrome c release from isolated mitochondria or permeabilized cells revisited. Biochim. Biophys. Acta 1457, 175-181.
2. Bernardi, P. (1996). The permeability transition pore. Control points of acyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta 1275, 5-9.
3. Bernardi, P., Vassanelli, S., Veronese, P., Colonna, R., Szabo, I., and Zoratti, M. (1992). Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 267, 2934-2939.
4. Berthiaume, J., and Wallace, K. B. (2002). Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis. Toxicol. Lett. 129, 23-32.
5. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem. 72, 248-254.
6. Broekemeier, K. M., Dempsey, M. E., and Pfeiffer, D. R. (1989). Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264, 7826-7830.
7. Cai, J., Yang, J., and Jones, D. P. (1998). Mitochondrial control of apoptosis: The role of cytochrome c. Biochim. Biophys. Acta 1366, 139-149.
8. Custodio, J. B., Palmeira, C. M., Moreno, A. J., and Wallace, K. B. (1998). Acrylic acid induces the glutathione-independent mitochondrial permeability transition in vitro. Toxicol. Sci. 43, 19-27.
9. Giesy, J. P., and Kannan, K. (2002). Perfluorochemical surfactants in the environment. Environ. Sci. Technol. 36, 146A-152A.
10. Gunter, K. K., and Gunter, T. E. (1994). Transport of calcium by mitochondria. J. Bioenerg. Biomembr. 26, 471-485.
11. Hansen, K. J., Clemen, L. A., Ellefson, M. E., and Johnson, H. O. (2001). Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35, 766-770.
12. Haughom, B., and Spydevold, O. (1992). The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim. Biophys. Acta 1128, 65-72.
13. Henry, T. R., and Wallace, K. B. (1995). Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol. Appl. Pharmacol. 134, 195-203.
14. Ikeda, T., Aiba, K., Fukuda, K., and Tanaka, M. (1985). The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J. Biochem. (Tokyo) 98, 475-482.
15. Kannan, K., Corsolini, S., Falandysz, J., Oehme, G., Focardi, S., and Giesy, J. P. (2002). Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas. Environ. Sci. Technol. 36, 3210-3216.
16. Kannan, K., Franson, J. C., Bowerman, W. W., Hansen, K. J., Jones, P. D., and Giesy, J. P. (2001). Perfluorooctane sulfonate in fish-eating water birds including bald eagles and albatrosses. Environ. Sci. Technol. 35, 3065-3070.
17. Keller, B. J., Marsman, D. S., Popp, J. A., and Thurman, R. G. (1992). Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta 1102, 237-244.
18. Kroemer, G., and Reed, J. C. (2000). Mitochondrial control of cell death. Nat. Med. 6, 513-519.
19. Luebker, D. J., Hansen, K. J., Bass, N. M., Butenhoff, J. L., and Seacat, A. M. (2002). Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology 176, 175-185.
20. Martin, J. W., Smithwick, M. M., Braune, B. M., Hoekstra, P. F., Muir, D. C., and Mabury, S. A. (2004). Identification of long-chain perfluorinated acids in biota from the Canadian Arctic. Environ. Sci. Technol. 38, 373-380.
21. McLennan, H. R., and Degli Esposti, M. (2000). The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J. Bioenerg. Biomembr. 32, 153-162.
22. Nieminen, A. L., Byrne, A. M., Herman, B., and Lemasters, J. J. (1997). Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am. J. Physiol. 272, C1286-C1294.
23. Olsen, G. W., Church, T. R., Larson, E. B., van Belle, G., Lundberg, J. K., Hansen, K. J., Burris, J. M., Mandel, J. H., and Zobel, L. R. (2004). Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 54, 1599-1611.
24. Olsen, G. W., Church, T. R., Miller, J. P., Burris, J. M., Hansen, K. J., Lundberg, J. K., Armitage, J. B., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., O'Neill, E. M., Mandel, J. H., and Zobel, L. R. (2003a). Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 111, 1892-1901.
25. Olsen, G. W., Hansen, K. J., Stevenson, L. A., Burris, J. M., and Mandel, J. H. (2003b). Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. Environ. Sci. Technol. 37, 888-891.
26. Palmeira, C. M., Rana, M. I., Frederick, C. B., and Wallace, K. B. (2000). Induction of the mitochondrial permeability transition in vitro by short-chain carboxylic acids. Biochem. Biophys. Res. Commun. 272, 431-435.
27. Panaretakis, T., Shabalina, I. G., Grander, D., Shoshan, M. C., and DePierre, J. W. (2001). Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol. Appl. Pharmacol. 173, 56-64.
28. Pastoor, T. P., Lee, K. P., Perri, M. A., and Gillies, P. J. (1987). Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. Exp. Mol. Pathol. 47, 98-109.
29. Petronilli, V., Costantini, P., Scorrano, L., Colonna, R., Passamonti, S., and Bernardi, P. (1994a). The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269, 16638-16642.
30. Petronilli, V., Nicolli, A., Costantini, P., Colonna, R., and Bernardi, P. (1994b). Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim. Biophys. Acta 1187, 255-259.
31. Renner, R. (2001). Growing concern over perfluorinated chemicals. Environ. Sci. Technol. 35, 154A-160A.
32. Schonfeld, P., and Bohnensack, R. (1997). Fatty acid-promoted mitochondrial permeability transition by membrane depolarization and binding to the ADP/ATP carrier. FEBS Lett. 420, 167-170.
33. Seacat, A. M., Thomford, P. J., Hansen, K. J., Clemen, L. A., Eldridge, S. R., Elcombe, C. R., and Butenhoff, J. L. (2003). Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 183, 117-131.
34. Seacat, A. M., Thomford, P. J., Hansen, K. J., Olsen, G. W., Case, M. T., and Butenhoff, J. L. (2002). Subchronic toxicity studies on perfluorooctane-sulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 68, 249-264.
35. Shabalina, I. G., Panaretakis, T., Bergstrand, A., and DePierre, J. W. (1999). Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells. Carcinogenesis 20, 2237-2246.
36. Starkov, A. A., and Wallace, K. B. (2002). Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol. Sci. 66, 244-252.
37. Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhoff, J. L., Stevenson, L. A., and Lau, C. (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol. Sci. 74, 369-381.
38. Zhou, S., Heller, L. J., and Wallace, K. B. (2001). Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats. Toxicol. Appl. Pharmacol. 175, 60-67.
39. Zhou, S., and Wallace, K. B. (1999). The effect of peroxisome proliferators on mitochondrial bioenergetics. Toxicol. Sci. 48, 82-89.
40. Zoratti, M., and Szabo, I. (1995). The mitochondrial permeability transition. Biochim. Biophys. Acta 1241, 139-176.